Targeted axillary dissection after neoadjuvant therapy in breast cancer
Authors:
- 28 February 2018
- journal article
- editorial
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 105 (4) , 313-314
Abstract
Enables de-escalation of surgeryKeywords
This publication has 8 references indexed in Scilit:
- Feasibility of magnetic marker localisation for non-palpable breast cancerThe Breast, 2017
- Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary DissectionJournal of Clinical Oncology, 2016
- Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph NodesAnnals of Surgical Oncology, 2016
- Improving the Accuracy of Axillary Lymph Node Surgery in Breast Cancer with Ultrasound-Guided Wire Localization of Biopsy Proven Metastatic Lymph NodesAnnals of Surgical Oncology, 2015
- Marking Axillary Lymph Nodes With Radioactive Iodine Seeds for Axillary Staging After Neoadjuvant Systemic Treatment in Breast Cancer PatientsAnnals of Surgery, 2015
- Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast CancerJAMA, 2013
- Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort studyThe Lancet Oncology, 2013
- Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2‐positive breast cancerCancer, 2010